These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31498280)

  • 21. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey.
    Hilsden RJ; Meddings JB; Verhoef MJ
    Can J Gastroenterol; 1999 May; 13(4):327-32. PubMed ID: 10360993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
    García-Planella E; Marín L; Domènech E; Bernal I; Mañosa M; Zabana Y; Gassull MA
    Med Clin (Barc); 2007 Jan; 128(2):45-8. PubMed ID: 17266900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of complementary and alternative medicine (CAM) in patients with inflammatory bowel disease (IBD): results from a German nationwide survey of 2019 compared to a previous survey of 2002.
    Bauer N; Kairey L; Schlee C; Uecker C; Öznur Ö; Langhorst J
    Scand J Gastroenterol; 2022 Oct; 57(10):1209-1215. PubMed ID: 35722930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
    Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
    Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.
    Bertomoro P; Renna S; Cottone M; Riegler G; Bossa F; Giglio L; Pastorelli L; Papi C; Castiglione F; Angelucci E; Pica R; Di Paolo MC; D'Incà R
    J Crohns Colitis; 2010 Sep; 4(3):291-300. PubMed ID: 21122518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.
    Oxelmark L; Lindberg A; Löfberg R; Sternby B; Eriksson A; Almer S; Befrits R; Fossum B; Karlén P; Broström O; Tysk C;
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1320-8. PubMed ID: 27472271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of complementary therapies by patients with IBD may indicate psychosocial distress.
    Langmead L; Chitnis M; Rampton DS
    Inflamm Bowel Dis; 2002 May; 8(3):174-9. PubMed ID: 11979137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
    Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
    Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD).
    Mousavi T; Nikfar S; Abdollahi M
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):865-888. PubMed ID: 33993811
    [No Abstract]   [Full Text] [Related]  

  • 31. Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.
    Mountifield R; Andrews JM; Mikocka-Walus A; Bampton P
    World J Gastroenterol; 2015 Mar; 21(12):3663-70. PubMed ID: 25834335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, quality of life, and use of complementary and alternative medicine and therapies in inflammatory bowel disease: a comparison of Chinese and Caucasian patients.
    Leong RW; Lawrance IC; Ching JY; Cheung CM; Fung SS; Ho JN; Philpott J; Wallace AR; Sung JJ
    Dig Dis Sci; 2004 Oct; 49(10):1672-6. PubMed ID: 15573925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
    Sirois FM
    Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Complementary and Alternative Therapies in People with Inflammatory Bowel Disease.
    Frank L; Lambert K
    Int J Environ Res Public Health; 2024 Aug; 21(9):. PubMed ID: 39338023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complementary and alternative medicine use by osteoporosis clinic patients.
    Chong CA; Diaz-Granados N; Hawker GA; Jamal S; Josse RG; Cheung AM
    Osteoporos Int; 2007 Nov; 18(11):1547-56. PubMed ID: 17603742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.
    Almakadma AH; De Vol A; Alabdaljabar MS; Aldosari S; Muhsen I; AlFreihi O; Kurdi A; Almadi M; Alsohaibani F
    Saudi J Gastroenterol; 2023; 29(4):233-239. PubMed ID: 37282444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
    Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.
    Wong AP; Clark AL; Garnett EA; Acree M; Cohen SA; Ferry GD; Heyman MB
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):55-60. PubMed ID: 19172124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.
    Regueiro M; Click B; Anderson A; Shrank W; Kogan J; McAnallen S; Szigethy E
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1777-1785. PubMed ID: 29654918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.